ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of the Benefit of Early Treatment With an Endothelin Inhibitor (Bosentan) in Patients With Sudden Blindness Due to Giant Cell Arteritis: CECIBO

Centre Hospitalier Universitaire de Nice · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
arteritis, giant cell, blindness and low vision, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 855846
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.